ࡱ> 78 l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1 Courier New1 Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)-**_($* #,##0_);_($* (#,##0);_($* "-"_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* "-"_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* "-"??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* "-"??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)6 0%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0)                + ) , *   Ј ~~ ؈ ~~#؈ ~~ ؈ ~~<#܈ ~~4#܈ ~~8#܈ ~~3#܈ ~~83ffff̙̙3f3fff3f3f33333f33& Balance SheetqIncome StatementK Cash Flows l  4  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??Income Statement Cash FlowsU } 8} $ } y} $ } y} $ 4                                 TherapeuticsMD, Inc. 8-K 02/20/2018 Balance Sheet December 31,  ~   ~   ASSETS  Current Assets:         Cash ~ 2O  ~ V4\ - %Accounts receivable, net of allowance  ~ 5   ~ n 7/for doubtful accounts of $380,580 and $376,374, respectively Inventory~ Z~ AOther current assets~ ~ RTotal current assets~ bE!~  @332211....      l  1;J  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Balance Sheet Cash FlowsU } a/} $ }  } $ }  }  $ } y} $ } y} $ } y} $ 1     TherapeuticsMD, Inc. 8-K 02/20/2018Income Statement'Three Months Ended December 31,  Year Ended December 31,  ~  ~  ~  ~  ~ ~              Revenues, net ~   ~   ~   ~ l  ~ l                       Cost of goods sold  ~ FM$   ~ >Q+   ~ >   ~ y   ~        Gross profit~ k~ Ғ  ~  _  ~ ~ \     Operating expenses:     *"Sales, general, and administrative~ :ja~   ~  *   ~ > ~ R Research and development~ ۝~ b,w  ~  9  ~ r ~ Z$-%Depreciation and amortization~ m~   ~     ~ ~      % Total operating expenses~ ~ Z^  ~  "*  ~ Z"~       Operating loss~ ~ zχ  ~  j}  ~ [{~ ^g      Other income     Miscellaneous income~ u~ 0  ~  >u*  ~ Vk~ Accreted interest ?~ z.  ~  Nx  ~ "~       Total other income~ u~ r_  ~  *  ~ v~ &     Dl{oWfjGK7;3 !"#$%&'()*+,-./0 Loss before income taxes  ~ -   ~ .   ~ ب   ~ o   ~ O !!!!!!!!!! ! ! ! ! !!!!!!!""Provision for income taxes"" "?""" "?"" "  " ?" " " "?""" "?"########## # # # # #######$Net loss$~ $-$$~ $.$$ ~ $ ب$ $ ~ $o$$~ $O$%%%%%%%%%% % % % % %%%%%%%*&"Loss per share, basic and diluted:&&&&&&&&& & & & & &&&&&&&'''''''''' ' ' ' ' '''''''-(%Net loss per share, basic and diluted(((((Q(( ( Gz׿( ( (q= ףpݿ(((\(\߿()))))))))) ) ) ) ) ))))))))*!Weighted average number of common********* * * * * *******/+' shares outstanding, basic and diluted++~ +*љ3+++~ +R.++ + ~ + b%1+ + +~ +F.+++~ +VI)+,-$.____________________________1/)Created by Morningstar Document Research.00(http://documentresearch.morningstar.com/&_@^=PF0*8X> @00//..(((((( (((($$$$$$ $$$$          l  4D`l  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Balance SheetIncome StatementU } U5} $ }  } $ } }  $ } } $ 4                                 TherapeuticsMD, Inc. 8-K 02/20/2018 Cash Flows Year Ended December, 31,   ~   ~   ~ ~ , $CASH FLOWS FROM OPERATING ACTIVITIES             Net loss ~ ب  ~ o  ~ O 0 (Adjustments to reconcile net loss to net            * "cash used in operating activities: Depreciation~ ~ J  ~   )!Amortization of intangible assets~ r]~ FT  ~   'Provision for doubtful accounts~ A~   ~  6Z  Share-based compensation~ }~ 6&  ~  Ӷ 4,Changes in operating assets and liabilities:    Accounts receivable~ .< ~ T   ~    Inventory~ ~ "n  ~   Other current assets~ \~ NT+  ~    Other assets ? ?  ~  z Accounts payable~ :8~ RR  ~  < Deferred revenue ? ?  ~  . !Other current liabilities~ Za~ >)  ~       -%Net cash used in operating activities~ ~   ~  '     ,$CASH FLOWS FROM INVESTING ACTIVITIES     Patent costs~ VJ~ h  ~  k  Purchase of fixed assets~ :~   ~   Dlu-iwEcOH% ! " # $ % & ' ( ) * + , - . / 0 1 2 3 # Payment of security deposit   ?   ~ $    ? !!!!!!!!!! ! ! ! -"%Net cash used in investing activities""~ "r"""~ "_"" " ~ " ^U" ########## # # # ,$$CASH FLOWS FROM FINANCING ACTIVITIES$$$$$$$$$ $ $ $ /%'Proceeds from sale of common stock, net%%~ %nWY%%%~ %i' %% % ~ % % &of costs)'!Proceeds from exercise of options''~ ' '''~ '^<'' ' ~ ' ;K' *("Proceeds from exercise of warrants((~ (^(((~ ("S(( ( ~ ( V( )))))))))) ) ) ) 1*)Net cash provided by financing activities**~ *0N***~ * ** * ~ * ** ++++++++++ + + + #,(Decrease) increase in cash,,~ ,މ,,,~ ,,, , ~ , ., !-Cash, beginning of period--~ -V4\---~ -\m-- - ~ - > - .Cash, end of period.~ .2O..~ .V4\.. ~ . \m. /0$1____________________________12)Created by Morningstar Document Research.03(http://documentresearch.morningstar.com/,# |EF"b =PF0*8X> @j 33 22 11 ......      Root Entry FBook  m  !"#$%&'()*+,-./0123456